These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1272 related articles for article (PubMed ID: 16900558)
1. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo. Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558 [TBL] [Abstract][Full Text] [Related]
2. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis. Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242 [TBL] [Abstract][Full Text] [Related]
3. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy. Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895 [TBL] [Abstract][Full Text] [Related]
4. A novel oncolytic adenovirus targeting to telomerase activity in tumor cells with potent. Zou W; Luo C; Zhang Z; Liu J; Gu J; Pei Z; Qian C; Liu X Oncogene; 2004 Jan; 23(2):457-64. PubMed ID: 14724574 [TBL] [Abstract][Full Text] [Related]
5. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin. Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637 [TBL] [Abstract][Full Text] [Related]
6. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells. Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613 [TBL] [Abstract][Full Text] [Related]
7. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma. Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304 [TBL] [Abstract][Full Text] [Related]
8. Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity. Irving J; Wang Z; Powell S; O'Sullivan C; Mok M; Murphy B; Cardoza L; Lebkowski JS; Majumdar AS Cancer Gene Ther; 2004 Mar; 11(3):174-85. PubMed ID: 14726958 [TBL] [Abstract][Full Text] [Related]
10. Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma. Zhu ZB; Chen Y; Makhija SK; Lu B; Wang M; Rivera AA; Yamamoto M; Wang S; Siegal GP; Curiel DT; McDonald JM Int J Oncol; 2006 Nov; 29(5):1319-29. PubMed ID: 17016667 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional targeting of tumors with a novel tumor-specific survivin promoter. Zhu ZB; Makhija SK; Lu B; Wang M; Kaliberova L; Liu B; Rivera AA; Nettelbeck DM; Mahasreshti PJ; Leath CA; Barker S; Yamaoto M; Li F; Alvarez RD; Curiel DT Cancer Gene Ther; 2004 Apr; 11(4):256-62. PubMed ID: 15017380 [TBL] [Abstract][Full Text] [Related]
12. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus. Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667 [TBL] [Abstract][Full Text] [Related]
13. A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms. Delgado-Enciso I; Cervantes-García D; Martínez-Dávila IA; Ortiz-López R; Alemany-Bonastre R; Silva-Platas CI; Lugo-Trampe A; Barrera-Saldaña HA; Galván-Salazar HR; Coronel-Tene CG; Sánchez-Santillán CF; Rojas-Martínez A J Gene Med; 2007 Oct; 9(10):852-61. PubMed ID: 17729237 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon. Akbulut H; Zhang L; Tang Y; Deisseroth A Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708 [TBL] [Abstract][Full Text] [Related]
15. Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model. Zhu DE; Höti N; Song Z; Jin L; Wu Z; Wu Q; Wu M Cancer Gene Ther; 2006 Aug; 13(8):762-70. PubMed ID: 16543917 [TBL] [Abstract][Full Text] [Related]
16. Midkine promoter-based conditionally replicative adenovirus for targeting midkine-expressing human bladder cancer model. Terao S; Shirakawa T; Kubo S; Bishunu A; Lee SJ; Goda K; Tsukuda M; Hamada K; Tagawa M; Takenaka A; Fujisawa M; Gotoh A Urology; 2007 Nov; 70(5):1009-13. PubMed ID: 17919690 [TBL] [Abstract][Full Text] [Related]
17. E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer. Fukuda K; Abei M; Ugai H; Seo E; Wakayama M; Murata T; Todoroki T; Tanaka N; Hamada H; Yokoyama KK Cancer Res; 2003 Aug; 63(15):4434-40. PubMed ID: 12907616 [TBL] [Abstract][Full Text] [Related]
18. ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo. Alonso MM; Cascallo M; Gomez-Manzano C; Jiang H; Bekele BN; Perez-Gimenez A; Lang FF; Piao Y; Alemany R; Fueyo J Cancer Res; 2007 Sep; 67(17):8255-63. PubMed ID: 17804740 [TBL] [Abstract][Full Text] [Related]
19. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression. Kuppuswamy M; Spencer JF; Doronin K; Tollefson AE; Wold WS; Toth K Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456 [TBL] [Abstract][Full Text] [Related]
20. A bidirectional Tet-dependent promotor construct regulating the expression of E1A for tight control of oncolytic adenovirus replication. Fechner H; Wang X; Picó AH; Wildner J; Suckau L; Pinkert S; Sipo I; Weger S; Poller W J Biotechnol; 2007 Jan; 127(4):560-74. PubMed ID: 17083991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]